brokerbase

About tradingpattern.net

The movement of a security's price over a specific time period.

dedicated to value creation and applying the scientific method in finance

Search


www.brokerbase.ch network - market statistics - weekly update

www.brokerbase.ch High dividend yield stocks

www.brokerbase.ch network

3M Activision Blizzard Adobe Systems Affimetrix Airlines Akamai Tech Alcoa Altera Amazon.com American Express American Tower Amgen Amylin Pharma Analyst Rating AngloGold Apollo Group Apple Applied Materials AT&T Autodesk Automatic Data Processing Baidu Bank of America Baxter Bed Bath & Beyond Blackrock Boeing Broadcom C.H. Robinson CA Caterpillar Celgene Cephalon Charts Check Point Software Chevron Cintas Corporation Cisco Systems Citigroup Citrix Coca Cola Cognizant Comcast Costco Wholesale Cree Dell DENTSPLY DIRECTV Discount, Variety Stores DISH Disney Dow 30 Downgrade Dr. Reddy's Laboratories Du Pont eBay Electronic Arts EMC Corporation Expedia Express Scripts Extreme Networks Exxon Mobil FANNIE MAE Fastenal First Solar Fiserv Flextronics FLIR Ford Foster Wheeler FREDDIE MAC Freeport-McMoRan Garmin Genentech General Electric Genzyme Gilead Sciences Golden Star Resources Goldman Sachs Google Hansen Natural Hardware Healthcare Hecla Mining Henry Schein Hewlett Packard Hologic Home Depot Human Genome Science IBM Illumina Industry Infosys Initial Recommendation Intel InterActive Corp Intuit Intuitive Surgical Johnson & Johnson Joy Global JP Morgan Juniper Networks KKR KLA-Tencor Kraft Foods Lam Research Level 3 Liberty Global Liberty Media Life Technologies Linear Technology Lockheed Martin Logitech Marvell Technology MasterCard Maxim Integrated McDonalds Merck Merril Lynch Microchip Technology Microsoft Millicom Morgan Stanley Nasdaq 100 NetApp NETFLIX Network Network Appliance Newmont Mining News Corporation NII Holdings Noble NVIDIA O'Reilly Automotive Occidental Petroleum Oracle PACCAR Patterson Paychex Petrohawk PETROLEO BRASILEIRO Pfizer Procter & Gamble Qualcomm Quanta Renhe Commercial Holdings Research in Motion Riverbed Technology Ross Stores Royal Gold Ryanair S&P 500 salesforce.com SanDisk Seagate Sears Holdings Semiconductor - Integrated Circuits Services Sigma-Aldrich Software Southwest Airlines Staples Starbucks Steel & Iron Steel Dynamics Stericycle Symantec Synaptics Technology Teva Texas Instruments Ticker Travelers Uncategorized United Continental Holdings United Technologies Upgrade Urban Outfitters VeriSign Verizon Vertex Pharmaceuticals Visa Wal Mart Warner Chilcott Wells Fargo Wynn Resorts Xilinx XTO Yahoo Zoltek

www.brokerbase.ch network - archived market statistics

Blogroll

Recent Posts

Vertex Pharmaceuticals

« Previous Entries

Vertex Pharmaceuticals buy – New Analyst Rating from Needham & Company, LLC

Wednesday, May 9th, 2012

Vertex Pharmaceuticals overweight – New Analyst Rating from Barclays Capital

Wednesday, May 9th, 2012

Vertex Pharm (VRTX) Upgrade from Hold to Buy – Analyst rating from Needham

Tuesday, May 8th, 2012

Vertex Pharmaceuticals overweight – New Analyst Rating from Barclays Capital

Thursday, April 12th, 2012

Vertex Pharmaceuticals neutral – New Analyst Rating from UBS AG

Thursday, March 29th, 2012

Vertex Pharmaceuticals neutral – New Analyst Rating from UBS AG

Wednesday, March 28th, 2012

Vertex Pharmaceuticals neutral – New Analyst Rating from Goldman Sachs Group Inc.

Monday, February 6th, 2012

Vertex Pharmaceuticals overweight – New Analyst Rating from Barclays Capital

Thursday, February 2nd, 2012

Vertex Pharmaceuticals outperform – New Analyst Rating from Credit Suisse Group

Friday, December 16th, 2011

Vertex Pharmaceuticals buy – New Analyst Rating from Citigroup Corp.

Monday, December 5th, 2011

Vertex Pharmaceuticals buy – New Analyst Rating from Citigroup Corp.

Wednesday, November 23rd, 2011

Vertex Pharmaceuticals buy – New Analyst Rating from Citigroup Corp.

Tuesday, November 22nd, 2011

Vertex Pharmaceuticals neutral – New Analyst Rating from Robert W. Baird & Co. Incorporated

Wednesday, November 9th, 2011

Vertex Pharm (VRTX) Downgrade from Outperform to Neutral – Analyst rating from Robert W. Baird

Tuesday, November 8th, 2011

Vertex Pharmaceuticals neutral – New Analyst Rating from Robert W. Baird & Co. Incorporated

Tuesday, November 8th, 2011

Vertex Pharm ( VRTX ) Downgrade from Outperform to Neutral($33) – Analyst rating from Robert W. Baird

Tuesday, November 8th, 2011

Vertex Pharmaceuticals sector perform – New Analyst Rating from RBC Capital Markets

Tuesday, November 8th, 2011

Vertex Pharm (VRTX) Downgrade from Outperform to Sector Perform – Analyst rating from RBC Capital Mkts

Monday, November 7th, 2011

Vertex Pharmaceuticals sector perform – New Analyst Rating from RBC Capital Markets

Monday, November 7th, 2011

Vertex Pharm ( VRTX ) Downgrade from Outperform to Sector Perform($48) – Analyst rating from RBC Capital Mkts

Monday, November 7th, 2011

Vertex Pharmaceuticals outperform – New Analyst Rating from RBC Capital Markets

Friday, October 14th, 2011

Vertex Pharmaceuticals outperform – New Analyst Rating from RBC Capital Markets

Thursday, October 13th, 2011

Vertex Pharmaceuticals buy – New Analyst Rating from Citigroup Corp.

Wednesday, October 5th, 2011

Vertex Pharm ( VRTX ) Upgrade from Mkt Perform to Mkt Outperform($53) – Analyst rating from JMP Securities

Tuesday, October 4th, 2011

Vertex Pharm (VRTX) Upgrade from Mkt Perform to Mkt Outperform – Analyst rating from JMP Securities

Tuesday, October 4th, 2011

Vertex Pharmaceuticals buy – New Analyst Rating from Citigroup Corp.

Wednesday, September 7th, 2011

Vertex Pharmaceuticals buy – New Analyst Rating from Citigroup Corp.

Tuesday, August 30th, 2011

Vertex Pharmaceuticals outperform – New Analyst Rating from William Blair

Thursday, August 18th, 2011

Vertex Pharm ( VRTX ) Initial Recommendation Neutral – Analyst rating from UBS

Thursday, July 7th, 2011

Vertex Pharm (VRTX) Initial Recommendation – Neutral – Analyst rating from UBS

Thursday, July 7th, 2011

Vertex Pharm (VRTX) Downgrade from Buy to Hold – Analyst rating from Brean Murray

Wednesday, May 4th, 2011

Vertex Pharm ( VRTX ) Downgrade from Buy to Hold – Analyst rating from Brean Murray

Wednesday, May 4th, 2011

Vertex Pharmaceuticals outperform – New Analyst Rating from RBC Capital Markets

Tuesday, April 5th, 2011

Vertex Pharmaceuticals overweight – New Analyst Rating from Piper Jaffray & Co.

Friday, February 25th, 2011

Vertex Pharmaceuticals hold – New Analyst Rating from ThinkEquity Partners LLC

Friday, February 25th, 2011

Vertex Pharmaceuticals buy – New Analyst Rating from Goldman Sachs Group Inc.

Friday, February 25th, 2011

Vertex Pharmaceuticals hold – New Analyst Rating from ThinkEquity Partners LLC

Thursday, February 24th, 2011

Vertex Pharmaceuticals buy – New Analyst Rating from Goldman Sachs Group Inc.

Wednesday, February 9th, 2011

Vertex Pharm ( VRTX ) Initial Recommendation Buy – Analyst rating from Brean Murray

Friday, January 28th, 2011

Vertex Pharm (VRTX) Initial Recommendation – Buy – Analyst rating from Brean Murray

Friday, January 28th, 2011

Vertex Pharmaceuticals outperform – New Analyst Rating from RBC Capital Markets

Thursday, December 23rd, 2010

Vertex Pharm ( VRTX ) Initial Recommendation Buy – Analyst rating from Dawson James

Thursday, October 7th, 2010

Vertex Pharm (VRTX) Initial Recommendation – Buy – Analyst rating from Dawson James

Thursday, October 7th, 2010

Vertex Pharm ( VRTX ) Downgrade from Mkt Outperform to Mkt Perform – Analyst rating from JMP Securities

Wednesday, September 8th, 2010

Vertex Pharm (VRTX) Downgrade from Mkt Outperform to Mkt Perform – Analyst rating from JMP Securities

Wednesday, September 8th, 2010 « Previous Entries